AlphaYouBR
Insider selling
Bobak R. Azamian sold $906K of Tarsus Pharmaceuticals, Inc. (TARS) stock
Bobak R. Azamian, President/CEO and Board Chair of Tarsus Pharmaceuticals, Inc. (TARS), sold 10,000 shares of TARS stock worth $906K, per an SEC Form 4 filed Sep 9, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 4, 2026, 5 days before it was made public.
TARS has moved -15.1% since the trade date, from $90.78 to $77.08 (Sep 22, 2026 close).
- Traded
- Sep 4, 2026
- Disclosed
- Sep 9, 2026
- Filing delay
- 5 days
- Price since
- -15.1%
- Role
- President/CEO and Board Chair
- Source
- SEC Form 4
More TARS insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.